Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.

Brnabic AJ, Kelin K, Ascher-Svanum H, Montgomery W, Kadziola Z, Karagianis J.

Int J Clin Pract. 2011 Sep;65(9):945-53. doi: 10.1111/j.1742-1241.2011.02743.x.

PMID:
21849009
2.

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.

Ascher-Svanum H, Peng X, Faries D, Montgomery W, Haddad PM.

BMC Psychiatry. 2009 Jul 29;9:46. doi: 10.1186/1471-244X-9-46.

3.

Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications.

Novick D, Haro JM, Bertsch J, Anand H, Jemiai N, Haddad PM.

Int Clin Psychopharmacol. 2012 Sep;27(5):275-82. doi: 10.1097/YIC.0b013e328354db12.

PMID:
22699789
4.

Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.

Hong J, Novick D, Brugnoli R, Bertsch J, Haro JM.

Hum Psychopharmacol. 2013 Sep;28(5):438-46. doi: 10.1002/hup.2328. Epub 2013 Jun 15.

PMID:
23775950
5.

A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.

Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM.

J Clin Psychiatry. 2009 Oct;70(10):1397-406. doi: 10.4088/JCP.09m05284yel.

PMID:
19906343
6.

Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary.

Bitter I, Katona L, Zámbori J, Takács P, Fehér L, Diels J, Bacskai M, Lang Z, Gyáni G, Czobor P.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1383-90. doi: 10.1016/j.euroneuro.2013.02.003. Epub 2013 Mar 7.

PMID:
23477752
7.

Predictors for starting depot administration of risperidone in chronic users of antipsychotics.

Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.

J Clin Psychopharmacol. 2008 Dec;28(6):625-30. doi: 10.1097/JCP.0b013e31818a6d10.

PMID:
19011430
8.

Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.

Offord S, Lin J, Mirski D, Wong B.

Adv Ther. 2013 Mar;30(3):286-97. doi: 10.1007/s12325-013-0016-5. Epub 2013 Mar 8.

PMID:
23483449
9.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
10.
11.

A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral.

Patel MX, de Zoysa N, Bernadt M, David AS.

J Clin Psychiatry. 2008 Oct;69(10):1548-56. Epub 2008 Sep 23.

PMID:
19192437
12.

Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.

Kirson NY, Weiden PJ, Yermakov S, Huang W, Samuelson T, Offord SJ, Greenberg PE, Wong BJ.

J Clin Psychiatry. 2013 Jun;74(6):568-75. doi: 10.4088/JCP.12r08167. Epub 2013 Apr 19. Review.

13.

Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.

Haro JM, Suarez D, Novick D, Brown J, Usall J, Naber D; SOHO Study Group.

Eur Neuropsychopharmacol. 2007 Mar;17(4):235-44. Epub 2006 Nov 29.

PMID:
17137759
14.

Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia.

Zhu B, Ascher-Svanum H, Shi L, Faries D, Montgomery W, Marder SR.

Psychiatr Serv. 2008 Mar;59(3):315-7. doi: 10.1176/appi.ps.59.3.315.

PMID:
18308914
15.

Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence.

Arango C, Bombín I, González-Salvador T, García-Cabeza I, Bobes J.

Eur Psychiatry. 2006 Jan;21(1):34-40. Epub 2005 Dec 19.

PMID:
16360311
16.

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.

Ciudad A, San L, Bernardo M, Olivares JM, Polavieja P, Valladares A, Gilaberte I.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):245-50. doi: 10.1016/j.pnpbp.2011.10.014. Epub 2011 Oct 26.

PMID:
22056291
17.

Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.

Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S.

J Clin Psychiatry. 2001 Jul;62(7):545-51.

PMID:
11488366
18.
19.
20.

Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study.

Haro JM, Novick D, Suarez D, Roca M.

J Psychiatr Res. 2009 Jan;43(3):265-73. doi: 10.1016/j.jpsychires.2008.06.001. Epub 2008 Jul 21.

PMID:
18644606

Supplemental Content

Support Center